Journal article
Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults
Annals of clinical psychiatry, Vol.13(3), pp.129-134
2001
DOI: 10.3109/10401230109148958
PMID: 11791949
Abstract
Abstract
Despite the increasing recognition of attention-deficit hyperactivity disorder (ADHD) in adults, there are few controlled trials demonstrating the effectiveness of pharmacological treatments, particularly with nonstimulants. One controlled trial found bupropion SR more effective than placebo in the treatment of ADHD adults. We conducted a controlled study to contrast the effectiveness of bupropion SR and methylphenidate to placebo in ADHD adults. A randomized, double-blind, parallel design was used in this study. Following a 7-day placebo lead-in, 30 ADHD (DSM-IV) subjects (18-60 years old) were randomized to bupropion, methylphenidate, or placebo for 7 weeks. Methylphenidate was titrated over 1 week to a maximum dose of 0.9 mg/kg/d divided into 3 doses while bupropion was titrated over 2 weeks to a maximum dose of 200 mg A.M. and 100 mg P.M. Response rates based on Clinical Global Impression improvement ratings in patients receiving bupropion, methylphenidate, and placebo were 64, 50, and 27%, respectively. The difference in response rates between active treatment and placebo was not statistically significant (p = 0.14). Neuropsychological testing demonstrated trends favoring drug treatment on measures of immediate recall and verbal fluency. While bupropion SR may be a viable clinical alternative for adults with ADHD, further investigation is needed.
Details
- Title: Subtitle
- Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults
- Creators
- Samuel Kuperman - Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa, 52242Paul J Perry - Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa, 52242Gary R Gaffney - Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa, 52242Brian C Lund - Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, Iowa, 52242Kristine A Bever-Stille - Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, Iowa, 52242Stephan Arndt - Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa, 52242Timothy L Holman - Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, Iowa, 52242David J Moser - Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa, 52242Jane S Paulsen - Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, Iowa, 52242
- Resource Type
- Journal article
- Publication Details
- Annals of clinical psychiatry, Vol.13(3), pp.129-134
- DOI
- 10.3109/10401230109148958
- PMID
- 11791949
- NLM abbreviation
- Ann Clin Psychiatry
- ISSN
- 1040-1237
- eISSN
- 1547-3325
- Publisher
- Informa UK Ltd
- Language
- English
- Date published
- 2001
- Academic Unit
- Pharmacy; Psychiatry; Stead Family Department of Pediatrics; Epidemiology; Psychological and Brain Sciences; Biostatistics; Nursing; Injury Prevention Research Center; Medicine Administration
- Record Identifier
- 9984003466502771
Metrics
80 Record Views